Biotech Values

[Mbledug Dewe]

Pollyvonwog is the one who posted the response of MNTA IR:

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=59162901

I was then just curious why did MNTA IR responded that way. That was why I asked the board about it in my first post of today. Meanwhile I did some googling and found out about the elimination of the term "non-approvable letter" by the FDA.

So my understanding is, if FDA's response to TEVA were before 2008, the term used would be "a non-approvable letter" instead of "a minor deficiency letter".